• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者中产生耐达托霉素屎肠球菌引起尿路感染的特征分析

Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient.

作者信息

Sorlózano Antonio, Panesso Diana, Navarro-Marí José María, Arias Cesar A, Gutiérrez-Fernández José

机构信息

José Gutiérrez-Fernández, Department of Microbiology, University of Granada Medical School, Av. de Madrid, 11 , 18012 Granada, Spain.

出版信息

Rev Esp Quimioter. 2015 Aug;28(4):207-9.

PMID:26200029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5668868/
Abstract

OBJECTIVES

Characterization of a urine isolate of daptomycin non-susceptible Enterococcus faecium recovered from a patient with kidney transplantation and no history of daptomycin exposure.

METHODS

After isolation in a urine sample, identification of E. faecium was confirmed by amplification of the E. faecium-specific gene encoding D-alanyl-D-alanine ligase (ddl) and daptomycin susceptibility testing was performed by E-test on cation-adjusted Mueller-Hinton agar. In order to determine the genetic bases of daptomycin resistance, the open reading frames of five genes previously associated with daptomycin resistance in enterococci were sequenced.

RESULTS

Substitutions in the response regulator LiaR (S19F) and cardiolipin synthase (R218Q) were identified.

CONCLUSIONS

To the best of our knowledge, this is the first characterization of emerging daptomycin resistance in E. faecium in a Spanish hospital in the absence of daptomycin exposure and in a renal transplant recipient.

摘要

目的

对从一名肾移植患者尿液中分离出的耐达托霉素屎肠球菌进行特征分析,该患者无达托霉素暴露史。

方法

从尿液样本中分离出屎肠球菌后,通过扩增编码D -丙氨酰 - D -丙氨酸连接酶(ddl)的屎肠球菌特异性基因来确认其身份,并在阳离子调整的穆勒 - 欣顿琼脂上通过E试验进行达托霉素敏感性测试。为了确定达托霉素耐药的遗传基础,对先前与肠球菌中达托霉素耐药相关的五个基因的开放阅读框进行了测序。

结果

在反应调节因子LiaR(S19F)和心磷脂合酶(R218Q)中发现了替代突变。

结论

据我们所知,这是西班牙一家医院中在无达托霉素暴露情况下且在肾移植受者中首次对屎肠球菌新出现的达托霉素耐药性进行的特征分析。

相似文献

1
Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient.肾移植受者中产生耐达托霉素屎肠球菌引起尿路感染的特征分析
Rev Esp Quimioter. 2015 Aug;28(4):207-9.
2
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.血液系统恶性肿瘤和造血干细胞移植患者中对达托霉素不敏感的肠球菌:一种新出现的威胁。
Ann Hematol. 2013 Jan;92(1):129-31. doi: 10.1007/s00277-012-1539-6. Epub 2012 Aug 7.
3
Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.接种效应对利奈唑烷耐药基因替换的屎肠球菌固有耐药株单用及联合β-内酰胺类药物疗效的影响
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00315-18. Print 2018 Aug.
4
Mechanisms of resistance to daptomycin in Enterococcus faecium.粪肠球菌对达托霉素的耐药机制
Antimicrob Agents Chemother. 2008 Mar;52(3):1167-70. doi: 10.1128/AAC.00774-07. Epub 2008 Jan 7.
5
Emergence of daptomycin-resistant Enterococcus faecium in a critically ill patient with postoperative intra-abdominal sepsis.一名患有术后腹腔内脓毒症的重症患者中出现了对达托霉素耐药的屎肠球菌。
Rev Esp Quimioter. 2015 Apr;28(2):109-10.
6
Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.在达托霉素治疗期间,耐万古霉素屎肠球菌定植菌株中出现对达托霉素不敏感的情况。
Int J Med Microbiol. 2015 Dec;305(8):902-9. doi: 10.1016/j.ijmm.2015.09.005. Epub 2015 Sep 12.
7
A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.肝移植受者中耐达托霉素屎肠球菌感染的单中心经验
Transpl Infect Dis. 2016 Jun;18(3):341-53. doi: 10.1111/tid.12523. Epub 2016 Apr 22.
8
Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden.瑞典斯德哥尔摩出现VanD型耐万古霉素屎肠球菌。
Clin Microbiol Infect. 2007 Jan;13(1):106-8. doi: 10.1111/j.1469-0691.2006.01569.x.
9
Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?达托霉素:在印度医疗环境中,它是耐万古霉素肠球菌尿路感染的一种可行治疗选择吗?
Indian J Med Microbiol. 2016 Jul-Sep;34(3):398-9. doi: 10.4103/0255-0857.188377.
10
Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.一名未曾接触过达托霉素的患者体内出现对达托霉素耐药的屎肠球菌。
J Hosp Infect. 2007 Apr;65(4):376-8. doi: 10.1016/j.jhin.2007.01.002. Epub 2007 Feb 20.

引用本文的文献

1
Daptomycin Resistance Occurs Predominantly in -Type Vancomycin-Resistant in Australasia and Is Associated With Heterogeneous and Novel Mutations.在澳大拉西亚地区,达托霉素耐药主要发生在耐万古霉素的菌株中,并且与异质性和新的突变相关。
Front Microbiol. 2021 Oct 20;12:749935. doi: 10.3389/fmicb.2021.749935. eCollection 2021.
2
An Adaptive Mutation in Enterococcus faecium LiaR Associated with Antimicrobial Peptide Resistance Mimics Phosphorylation and Stabilizes LiaR in an Activated State.粪肠球菌LiaR中与抗菌肽抗性相关的适应性突变模拟磷酸化并使LiaR稳定在激活状态。
J Mol Biol. 2016 Nov 6;428(22):4503-4519. doi: 10.1016/j.jmb.2016.09.016. Epub 2016 Sep 23.

本文引用的文献

1
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.在一组接受达托霉素治疗的耐甲氧西林金黄色葡萄球菌持续性菌血症患者中出现了对达托霉素的耐药性。
J Antimicrob Chemother. 2014 Feb;69(2):568-71. doi: 10.1093/jac/dkt396. Epub 2013 Oct 9.
2
A current perspective on daptomycin for the clinical microbiologist.当前临床微生物学家视角下的达托霉素
Clin Microbiol Rev. 2013 Oct;26(4):759-80. doi: 10.1128/CMR.00030-13.
3
Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome.在达托霉素治疗期间,屎肠球菌中高水平达托霉素耐药性的演变与细菌基因组中的有限突变有关。
J Antimicrob Chemother. 2013 Aug;68(8):1926-8. doi: 10.1093/jac/dkt117. Epub 2013 Apr 11.
4
Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.达托霉素中介屎肠球菌和万古霉素耐药肠球菌的流行病学研究。
Infect Control Hosp Epidemiol. 2012 Dec;33(12):1250-4. doi: 10.1086/668438. Epub 2012 Oct 25.
5
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.达托霉素暴露先于达托霉素不敏感肠球菌感染和/或定植。
Antimicrob Resist Infect Control. 2012 May 29;1(1):19. doi: 10.1186/2047-2994-1-19.
6
Performance of the Sysmex UF1000i system in screening for significant bacteriuria before quantitative culture of aerobic/facultative fast-growth bacteria in a reference hospital.Sysmex UF1000i 系统在参考医院定量培养需氧/兼性快速生长菌前筛查显著菌尿的性能。
J Appl Microbiol. 2012 Sep;113(3):609-14. doi: 10.1111/j.1365-2672.2012.05369.x. Epub 2012 Jul 24.
7
Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins.达托霉素介导的膜结构重排导致必需的细胞分裂蛋白定位错误。
J Bacteriol. 2012 Sep;194(17):4494-504. doi: 10.1128/JB.00011-12. Epub 2012 Jun 1.
8
[Enterococcus: phenotype and genotype resistance and epidemiology in Spain].[肠球菌:西班牙的表型和基因型耐药性及流行病学]
Enferm Infecc Microbiol Clin. 2011 Dec;29 Suppl 5:59-65. doi: 10.1016/S0213-005X(11)70045-3.
9
Genetic basis for in vivo daptomycin resistance in enterococci.肠球菌体内达托霉素耐药的遗传基础。
N Engl J Med. 2011 Sep 8;365(10):892-900. doi: 10.1056/NEJMoa1011138.
10
Genetic basis for daptomycin resistance in enterococci.肠球菌中达托霉素耐药的遗传基础。
Antimicrob Agents Chemother. 2011 Jul;55(7):3345-56. doi: 10.1128/AAC.00207-11. Epub 2011 Apr 18.